The differences between control subjects and patients with MCI and between patients with MCI and patients with AD were highly significant for ApoE4 status, cognition and all four CSF markers.
← all excerpts
Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
1
—
—